Bullisch
$57.87
Szenariopreis
$71.560
-0.100 (-0.14%)Zum Schluss
Altria Group, Inc. operates a portfolio of tobacco products for United States tobacco consumers aged 21+. Its segments include smokeable products and oral tobacco products. The smokeable products segment consists of combustible cigarettes and machine-made large cigars. The oral tobacco products segment includes moist smokeless tobacco (MST) products and oral nicotine pouches. Its wholly owned subsidiaries include manufacturers of both combustible and smoke-free products. In combustibles, it owns Philip Morris USA Inc. (PM USA), and John Middleton Co. (Middleton), which are cigarette manufacturers. Its smoke-free portfolio includes ownership of U.S. Smokeless Tobacco Company LLC (USSTC), a global MST manufacturer, Helix Innovations LLC (Helix), a manufacturer of oral nicotine pouches, and NJOY, LLC (NJOY), an e-vapor manufacturer with a commercialized product portfolio. The brand portfolios of its operating companies include Marlboro, Black & Mild, Copenhagen, Skoal, on! and NJOY.
Altria Group Inc is a good buy right now due to its current price of $71.68, which is below the analyst price target of $79 from UBS, indicating potential upside of 10.5%. Additionally, the forward P/E ratio of 11.89 suggests the stock is undervalued compared to its earnings potential. However, the main risk is the negative sentiment from Barclays, which has a lower target of $58, representing a downside risk of 19%.
Barclays
$58
2026-08-11
Barclays
2026-08-11
Kursziel
$58
BTIG
—
2026-07-21
BTIG
2026-07-21
Kursziel
—
UBS
$79
2026-07-07
UBS
2026-07-07
Kursziel
$79
Barclays
$64
2026-05-15
Barclays
2026-05-15
Kursziel
$64
Deutsche Bank
$66
2026-05-04
Deutsche Bank
2026-05-04
Kursziel
$66
Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

Five Consumer Companies' Cash Management Strategies

Rising Negative Beta Phenomenon in S&P 500 Stocks

Dividend Kings: Investment Value of Coca-Cola and Altria

Altria Group Marks 61st Dividend Increase

Altria Group Marks 61st Dividend Increase
Altria Group, Inc. operates a portfolio of tobacco products for United States tobacco consumers aged 21+. Its segments include smokeable products and oral tobacco products. The smokeable products segment consists of combustible cigarettes and machine-made large cigars. The oral tobacco products segment includes moist smokeless tobacco (MST) products and oral nicotine pouches. Its wholly owned subsidiaries include manufacturers of both combustible and smoke-free products. In combustibles, it owns Philip Morris USA Inc. (PM USA), and John Middleton Co. (Middleton), which are cigarette manufacturers. Its smoke-free portfolio includes ownership of U.S. Smokeless Tobacco Company LLC (USSTC), a global MST manufacturer, Helix Innovations LLC (Helix), a manufacturer of oral nicotine pouches, and NJOY, LLC (NJOY), an e-vapor manufacturer with a commercialized product portfolio. The brand portfolios of its operating companies include Marlboro, Black & Mild, Copenhagen, Skoal, on! and NJOY. It operates in the Consumer Non-Cyclicals sector (CIGARETTES industry).
Altria Group Inc is a good buy right now due to its current price of $71.68, which is below the analyst price target of $79 from UBS, indicating potential upside of 10.5%. Additionally, the forward P/E ratio of 11.89 suggests the stock is undervalued compared to its earnings potential. However, the main risk is the negative sentiment from Barclays, which has a lower target of $58, representing a downside risk of 19%.
14 analysts cover MO: 8 rate it Buy, 6 Hold and 0 Sell. The average price target is 65.00.

$MO Altria is now sitting on a key horizontal level. This shaded zone has acted as both support and resistance at different times throughout this year. It may need to consolidate for about another month and get tighter and closer to the apex of the triangle before we see a breakout.
Mehr anzeigenDiese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.